Ovid Therapeutics Stock Price History
| OVID Stock | USD 1.13 0.00 0.00% |
Below is the normalized historical share price chart for Ovid Therapeutics extending back to May 05, 2017. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Ovid Therapeutics stands at 1.13, as last reported on the 29th of November, with the highest price reaching 1.13 and the lowest price hitting 1.09 during the day.
If you're considering investing in Ovid Stock, it is important to understand the factors that can impact its price. At this point, Ovid Therapeutics is very risky. Ovid Therapeutics maintains Sharpe Ratio (i.e., Efficiency) of 0.0317, which implies the firm had a 0.0317% return per unit of risk over the last 3 months. We have found twenty-one technical indicators for Ovid Therapeutics, which you can use to evaluate the volatility of the company. Please check Ovid Therapeutics' Coefficient Of Variation of (2,658), variance of 14.56, and Risk Adjusted Performance of (0.02) to confirm if the risk estimate we provide is consistent with the expected return of 0.12%.
The current year's Stock Based Compensation To Revenue is expected to grow to 19.53, whereas Total Stockholder Equity is forecasted to decline to about 83.4 M. . At present, Ovid Therapeutics' Price Book Value Ratio is projected to drop based on the last few years of reporting. The current year's Price To Book Ratio is expected to grow to 3.82, whereas Price Earnings To Growth Ratio is projected to grow to (3.01). Ovid Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 5th of May 2017 | 200 Day MA 1.9555 | 50 Day MA 1.1552 | Beta 0.41 |
Ovid |
Sharpe Ratio = 0.0317
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | OVID | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 3.7 actual daily | 32 68% of assets are more volatile |
Expected Return
| 0.12 actual daily | 2 98% of assets have higher returns |
Risk-Adjusted Return
| 0.03 actual daily | 2 98% of assets perform better |
Based on monthly moving average Ovid Therapeutics is performing at about 2% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Ovid Therapeutics by adding it to a well-diversified portfolio.
Price Book 1.0332 | Enterprise Value Ebitda (0.69) | Price Sales 124.777 | Shares Float 46.5 M | Wall Street Target Price 3.26 |
Ovid Therapeutics Stock Price History Chart
There are several ways to analyze Ovid Stock price data. The simplest method is using a basic Ovid candlestick price chart, which shows Ovid Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | November 11, 2024 | 1.36 |
| Lowest Price | September 6, 2024 | 1.02 |
Ovid Therapeutics November 29, 2024 Stock Price Synopsis
Various analyses of Ovid Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Ovid Stock. It can be used to describe the percentage change in the price of Ovid Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Ovid Stock.| Ovid Therapeutics Price Action Indicator | 0.02 | |
| Ovid Therapeutics Price Rate Of Daily Change | 1.00 |
Ovid Therapeutics November 29, 2024 Stock Price Analysis
Ovid Stock Price History Data
The price series of Ovid Therapeutics for the period between Sat, Aug 31, 2024 and Fri, Nov 29, 2024 has a statistical range of 0.34 with a coefficient of variation of 6.15. The daily prices for the period are spread out with arithmetic mean of 1.15. The median price for the last 90 days is 1.14.| Open | High | Low | Close | Volume | ||
11/29/2024 | 1.12 | 1.12 | 1.09 | 1.12 | ||
11/29/2024 | 1.12 | 1.12 | 1.09 | 1.12 | ||
| 11/27/2024 | 1.10 | 1.12 | 1.09 | 1.11 | 102,146 | |
| 11/26/2024 | 1.08 | 1.10 | 1.08 | 1.09 | 120,531 | |
| 11/25/2024 | 1.08 | 1.12 | 1.07 | 1.10 | 267,870 | |
| 11/22/2024 | 1.06 | 1.07 | 1.02 | 1.05 | 162,093 | |
| 11/21/2024 | 1.05 | 1.07 | 1.01 | 1.06 | 123,658 | |
| 11/20/2024 | 1.02 | 1.06 | 1.02 | 1.04 | 216,267 | |
| 11/19/2024 | 1.03 | 1.06 | 0.99 | 1.03 | 267,623 | |
| 11/18/2024 | 1.09 | 1.09 | 1.02 | 1.04 | 489,307 | |
| 11/15/2024 | 1.17 | 1.19 | 1.03 | 1.06 | 437,654 | |
| 11/14/2024 | 1.22 | 1.23 | 1.14 | 1.15 | 136,118 | |
| 11/13/2024 | 1.23 | 1.27 | 1.11 | 1.22 | 387,670 | |
| 11/12/2024 | 1.38 | 1.39 | 1.24 | 1.24 | 239,265 | |
| 11/11/2024 | 1.32 | 1.47 | 1.31 | 1.36 | 875,178 | |
| 11/08/2024 | 1.28 | 1.32 | 1.27 | 1.30 | 156,090 | |
| 11/07/2024 | 1.30 | 1.37 | 1.25 | 1.30 | 296,236 | |
| 11/06/2024 | 1.27 | 1.31 | 1.13 | 1.30 | 432,678 | |
| 11/05/2024 | 1.18 | 1.25 | 1.14 | 1.25 | 146,628 | |
| 11/04/2024 | 1.12 | 1.20 | 1.11 | 1.18 | 134,671 | |
| 11/01/2024 | 1.15 | 1.19 | 1.10 | 1.14 | 167,288 | |
| 10/31/2024 | 1.15 | 1.16 | 1.13 | 1.13 | 95,010 | |
| 10/30/2024 | 1.21 | 1.21 | 1.15 | 1.15 | 96,572 | |
| 10/29/2024 | 1.17 | 1.20 | 1.16 | 1.19 | 96,628 | |
| 10/28/2024 | 1.20 | 1.22 | 1.13 | 1.17 | 181,624 | |
| 10/25/2024 | 1.22 | 1.23 | 1.18 | 1.18 | 62,944 | |
| 10/24/2024 | 1.19 | 1.22 | 1.19 | 1.21 | 63,700 | |
| 10/23/2024 | 1.18 | 1.24 | 1.15 | 1.20 | 91,686 | |
| 10/22/2024 | 1.18 | 1.21 | 1.17 | 1.19 | 96,168 | |
| 10/21/2024 | 1.20 | 1.22 | 1.17 | 1.19 | 131,111 | |
| 10/18/2024 | 1.18 | 1.23 | 1.17 | 1.22 | 195,024 | |
| 10/17/2024 | 1.17 | 1.18 | 1.13 | 1.17 | 83,737 | |
| 10/16/2024 | 1.15 | 1.19 | 1.15 | 1.18 | 75,947 | |
| 10/15/2024 | 1.12 | 1.18 | 1.10 | 1.15 | 124,094 | |
| 10/14/2024 | 1.19 | 1.19 | 1.10 | 1.14 | 117,565 | |
| 10/11/2024 | 1.07 | 1.15 | 1.03 | 1.15 | 154,750 | |
| 10/10/2024 | 1.07 | 1.12 | 1.06 | 1.09 | 86,742 | |
| 10/09/2024 | 1.10 | 1.18 | 1.06 | 1.10 | 93,303 | |
| 10/08/2024 | 1.17 | 1.17 | 1.08 | 1.10 | 103,631 | |
| 10/07/2024 | 1.15 | 1.17 | 1.12 | 1.13 | 48,447 | |
| 10/04/2024 | 1.13 | 1.18 | 1.10 | 1.15 | 69,040 | |
| 10/03/2024 | 1.13 | 1.15 | 1.10 | 1.13 | 63,686 | |
| 10/02/2024 | 1.13 | 1.15 | 1.11 | 1.13 | 52,631 | |
| 10/01/2024 | 1.17 | 1.17 | 1.11 | 1.12 | 83,251 | |
| 09/30/2024 | 1.18 | 1.19 | 1.15 | 1.18 | 61,648 | |
| 09/27/2024 | 1.12 | 1.19 | 1.12 | 1.18 | 103,297 | |
| 09/26/2024 | 1.11 | 1.14 | 1.09 | 1.12 | 218,652 | |
| 09/25/2024 | 1.17 | 1.17 | 1.10 | 1.12 | 137,184 | |
| 09/24/2024 | 1.12 | 1.15 | 1.07 | 1.14 | 104,072 | |
| 09/23/2024 | 1.13 | 1.15 | 1.09 | 1.11 | 93,000 | |
| 09/20/2024 | 1.19 | 1.19 | 1.14 | 1.15 | 402,974 | |
| 09/19/2024 | 1.11 | 1.17 | 1.06 | 1.17 | 112,638 | |
| 09/18/2024 | 1.13 | 1.15 | 1.03 | 1.06 | 225,542 | |
| 09/17/2024 | 1.20 | 1.20 | 1.11 | 1.12 | 130,475 | |
| 09/16/2024 | 1.20 | 1.20 | 1.13 | 1.17 | 78,915 | |
| 09/13/2024 | 1.13 | 1.19 | 1.11 | 1.19 | 199,678 | |
| 09/12/2024 | 1.10 | 1.13 | 1.09 | 1.11 | 69,959 | |
| 09/11/2024 | 1.10 | 1.13 | 1.05 | 1.12 | 119,433 | |
| 09/10/2024 | 1.08 | 1.13 | 1.04 | 1.11 | 101,116 | |
| 09/09/2024 | 1.00 | 1.09 | 0.98 | 1.07 | 190,571 | |
| 09/06/2024 | 1.11 | 1.12 | 0.96 | 1.02 | 249,644 |
About Ovid Therapeutics Stock history
Ovid Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Ovid is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Ovid Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Ovid Therapeutics stock prices may prove useful in developing a viable investing in Ovid Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 70.6 M | 44 M | |
| Net Loss | -62.3 M | -59.2 M |
Ovid Therapeutics Quarterly Net Working Capital |
|
Ovid Therapeutics Stock Technical Analysis
Ovid Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Competition Analyzer Now
Competition AnalyzerAnalyze and compare many basic indicators for a group of related or unrelated entities |
| All Next | Launch Module |
Ovid Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Ovid Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Ovid Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Ovid to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.02) | |||
| Jensen Alpha | (0.43) | |||
| Total Risk Alpha | (0.73) | |||
| Treynor Ratio | (0.06) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Ovid Stock analysis
When running Ovid Therapeutics' price analysis, check to measure Ovid Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ovid Therapeutics is operating at the current time. Most of Ovid Therapeutics' value examination focuses on studying past and present price action to predict the probability of Ovid Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ovid Therapeutics' price. Additionally, you may evaluate how the addition of Ovid Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal |